GSK plc
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| 6-K | TRANSACTION IN OWN SHARES | Mar 27, 2026 |
| 6-K | BEPIROVIRSEN ACCEPTED FOR REVIEW BY THE EMA | Mar 27, 2026 |
| 6-K | TRANSACTION IN OWN SHARES | Mar 26, 2026 |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Mar 25, 2026 |
| 6-K | NOTICE OF AGM | Mar 25, 2026 |
| 6-K | TRANSACTION IN OWN SHARES | Mar 25, 2026 |
| 6-K | TRANSACTION IN OWN SHARES | Mar 24, 2026 |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Mar 23, 2026 |
| 6-K | ADMISSION TO TRADING | Mar 23, 2026 |
| 6-K | GSK LUNG CANCER ADC GETS JAPAN ORPHAN DRUG STATUS | Mar 23, 2026 |
Insider Transactions
View all →No insider transactions loaded yet.